Resources

For Providers

Anatomic pathology

Urological Pathology

Your trusted leader in genitourinary testing services.

Gastrointestinal Pathology

Your trusted leader in GI/Liver testing services.

Myeloid68NGS

Myeloid68 uses targeted next-generation sequencing (NGS) to detect somatic alterations in 68 genes associated with myeloid malignancies.

Hematopathology

Hematopathology Trifold

Hematopathology Requisition

Chronic Lymphocytic Leukemia

GoPath Laboratories offers a complete testing solution for your CLL patients, including morphology, flow cytometry, FISH, cytogenetics, lgVH testing, B-cell receptor stereotyping, and minimal residual disease monitoring.

Test Menu

Full Service Test Menu

Molecular, FISH, Flow Cytometry, Histology, Cytology

For Individuals

Prostate cancer

Prostate cancer patient guide

PROSTATENOW™ is a genetic test for men with prostate cancer or those at risk of developing prostate cancer.

Breast & Ovarian cancer

Breast Cancer Patient Guide

BRCANOW® is a next-generation sequencing panel for people with a personal or family history of breast or ovarian cancer.

Colon cancer

Colon Cancer Patient Guide

LYNCHNOW® is a germline screening tool to test for Lynch syndrome and other hereditary cancer disorders in patients with colorectal cancer.

For Providers

PROSTATENOW™

PROSTATENOW™ Physician Brochure

PROSTATENOW™ is a clinical grade comprehensive germline panel offered by GoPath Diagnostics.

Dr. Brian Helfand

Brian T. Helfand, MD, Ph.D.; Division Head of Urology – NorthShore Medical Group

PROSTATENOW™ Gene list

The core of germline testing is to know which genes/mutations have clinical validity and utility. The genes tested in PROSTATENOW™ are based on a combination of clinical guidelines and up-to-date evidence-based review.

Dr. Jim Lu

Jim Lu MD, Ph.D.; President, CEO and Medical Director; 15+ Years of Experience in GI and Liver Pathology

Dr. Jianfeng Xu

Jianfeng Xu, DrPH; Vice President, Translational Research; Director, Program for Personalized Cancer Care

Prostate Cancer Flyer

A Comprehensive Germline Panel for Prostate Cancer

Articles

Active Surveillance Paper BRCA + ATM

HGG Advances

Genetic factors associated with prostate cancer conversion from active surveillance to treatment

European Association of Urology

Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis

Genetic Testing For Prostate Cancer Tackles The Black Demographic Disparity

Association of Prostate Cancer Polygenic Risk Score

BRCANOW®

BRCANOW Gene list

BRCANOW is a Next-Gen Sequencing (NGS)-based assay using a state-of-the-art platform developed exclusively at GoPath Laboratories.

LYNCHNOW®

LynchNow® Flyer

GoPath offers a comprehensive step-by-step and cost-effective lynch screening program.

COMPREHENSIVE

GeneticsNow® Gene List

Bringing solutions to genetic testing. GoPath's GeneticsNow® Series includes a collection of next-generation sequencing panels that detect germline variants associated with an increased risk for various hereditary cancers.

Genetic Counseling

Genetic Counselor Dani Bishay

Dani Bishay, MS, CGC. Certified Genetic Counselor. 10+ Years in Genetic Counseling.

Genetic Counselor TinaMarie Bauman

TinaMarie Bauman RN, MSN, APN, AGN-BC. Hereditary Cancer Genetics Nurse. 20+ Years of Experience in Genetics Counseling and Oncology Nursing.

Genetic Counselor Scott M. Weissmann

Scott M. Weissmann, MS, CGC. Certified Genetic Counselor. 15+ Years in Genetic Counseling.

Genetic Counseling

Next Generation of Hereditary Genetic Testing

Requisitions

PROSTATENOW™ Hereditary Requisition

GeneticsNow® Hereditary Requisition

For Individuals

Flyers

OncoTarget®500 Patient Guide

OncoTarget® 500 is a comprehensive genomic profiling panel that analyzes over 500 genes to detect genomic alterations known to alter cancer growth.

For Providers

Brochures

OncoTarget®500 Physician brochure

FDA-Cleared IVD Comprehensive Genomic Profiling Panel.

Infopages

OncoTarget®500 Tech Sheet

Genomic Profiling Powered by GoPath Diagnostics.

OncoTarget®500 Infopage

Unique Advantages of OncoTarget500®. Fast. Proven. Actionable.

Collaboration with Duke University

Requisitions

Genomic Requisition

Infopage - OncoTracking™

Monitor Treatments. Early Treatment. Track.

GoPath® Diagnostics Launches FDA-Cleared CGP Test under OncoTarget® 500
#ASCO22 week is here and we are excited to announce the release of our FDA-Cleared CGP Test under OncoTarget® 500.

Visit us in booth #28109 on June 4-6 between 9:00 AM–5:00 PM each day and learn how this CGP solution will help advance cancer treatments by identifying genomic targets for both targeted therapy and immunotherapy.
Read more